Storytelling is a part of J Freireich’s legacy

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

J enjoyed explaining that the letter J in his name appeared in his birth certificate.

Emil J Freireich in 2016.
Photo courtesy of MD Anderson Cancer Center

He had no idea why his mother, an immigrant seamstress at a Chicago sweatshop, put it there, but it was certainly not an abbreviation for an actual name, Jacob, for example.

J’s J was its own thing. No period was to be used.

Great stories beautifully told are a part of J’s legacy. He spoke with reporters and historians, leaving behind more primary source material than your average Joe.

Emil J Freireich died Feb. 1, aged 93, at MD Anderson Cancer Center.

Here are J’s stories in his own words:

  • Freireich’s conversation with Daniel Hayes, a breast cancer expert at the University of Michigan and former president of the American Society of Clinical Oncology, is particularly entertaining.

  • There is also a beautifully annotated, three-session, seven-hour oral history done by MD Anderson.

  • NIH historians, too, sat down with Freireich. The interview appears here.

  • Another fine resource is a book by John Laszlo, “The Cure of Childhood Leukemia: Into the Age of Miracles.” Laszlo, both a participant and a historian of these events, records a lengthy conversation with Freireich and makes it a part of the narrative.

In this issue, we supplement J’s storytelling with an obituary by MD Anderson, and appreciations by Hagop Kantarjian, Moshe Talpaz, and Otis Brawley.

Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 
Paul Goldberg
Editor & Publisher

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login